Parallel distribution of original quality products

Parallel trade makes original innovative medicines available at lower costs and provides both direct and indirect savings to social health insurance systems, other third-party payers and consumers.

MPA Pharma acquires majority stake

MPA Pharma Handshake

In April 2012 Germany's MPA Pharma acquired a majority stake in Paranova A/S. For 30 years MPA Pharma and its sales subsidiary EMRAmed have been leading reimporters ...

Read more …

International Presence


More Information

Low-priced originals!

Paranova buys pharmaceuticals from licensed wholesalers in virtually every country in the EU/EES. To be able to market these products in the country of destination the parallel importer must be provided with a marketing authorization – one license for each product and each country of origin.